Excision BioTherapeutics is a private company focused on developing advanced gene editing therapeutics to address the medical need for the treatment of life-threatening disease caused by viral infections. Our mission is to advance gene editing therapeutics for our indications into safe and efficacious medicines that will greatly improve the lives of infected individuals around the world.
Location: United States, California, San Francisco
Employees: 11-50
Founded date: 2015
Investors 7
Mentions in press and media 9
| Date | Title | Description |
| 31.10.2023 | Health | CRISPR gene editing could kill HIV. But is it a cure? | In a provocative first step toward an elusive end to a devastating disease that has claimed 40 million lives, three patients have received CRISPR gene-editing therapies in an effort to eradicate HIV from their bodies. The results — whether ... |
| 11.10.2022 | A Bold Effort To Cure HIV—Using Crispr | IN JULY, AN HIV-positive man became the first volunteer in a clinical trial aimed at using Crispr gene editing to snip the AIDS-causing virus out of his cells. For an hour, he was hooked up to an IV bag that pumped the experimental treatmen... |
| 28.01.2022 | Excision BioTherapeutics Initiates Phase 1/2 Trial Evaluating EBT-101 as a Potential Cure for HIV | The FIH study is a multicenter, open-label, single ascending dose study designed to evaluate the safety, tolerability and efficacy of EBT-101. The trial is supported by a robust preclinical dataset that includes both positive long-term non-... |
| 30.08.2021 | Excision Announces NIH Martin Delaney Grant Awarded to Temple University to Support “CRISPR for Cure” for HIV | annual funding from the NIH to find a cure for HIV. Research will be done at Temple University, as well as the University of California, Los Angeles, Washington University School of Medicine, St. Louis, Case Western Reserve University, Drex... |
| 17.02.2021 | Virus-Fighting Company Aimed at Knocking out HIV Raises $60M | Excision BioTherapeutics, with offices in San Francisco and Philadelphia, said the round was led by GreatPoint Ventures and included existing investor ARTIS Ventures plus new investors Adjuvant Capital, Norwest Venture Partners, Anzu Partne... |
| 27.07.2020 | Biopharma Tackles COVID-19, HIV and Other Viruses with Gene and Cell Therapies | Deploying CRISPR against hidden HIV reservoirs Even though antiretroviral drugs can tamp down the virus to the point where it’s no longer detectable in the blood, it can hide out in “reservoirs” and emerge later. Excision licensed gene-edit... |
| 18.06.2020 | Ben Franklin Approved $1.48M in 7 Early Stage Companies | |
| 05.06.2020 | 15 Biotech Companies in Philadelphia at the Helm of Research and Discovery | Like many tech hubs, the City of Brotherly Love has been at the helm of invention and disruption for the past several decades, giving rise to some of the country’s most impressive tech companies and startups. And while Philly’s tech scene s... |
| 16.03.2020 | Ben Franklin Companies Fighting Infectious Disease and its Effects | While southeastern Pennsylvania has numerous large companies working on novel technologies to address these issues across many aspects of pandemic mitigation – vaccines, therapeutics, diagnostics, surveillance/epidemiology, devices, manufac... |